Status:
COMPLETED
Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients
Lead Sponsor:
Stanford University
Conditions:
Breast Cancer
Depression, Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to:Translate a mindfulness program into Spanish for Latina patients with breast cancer.Train a community health worker to facilitate the mindfulness program. Determine if t...
Detailed Description
Primary aims of this study are to: 1) translate a behavioral health intervention into Spanish, 2) deliver it to a population of Spanish speaking Latina breast cancer patients, and 3) determine accepta...
Eligibility Criteria
Inclusion
- Self reported diagnosis of invasive breast cancer who has currently or within last 12 months been in active treatment (surgery, chemotherapy, or radiation) or on endocrine therapy
- Self-identified anxiety (persistent worry or nervousness), depression (feeling sad, little interest or pleasure in doing things or hopeless), or sleep disturbance.
- Breast cancer related treatment (surgery, radiation, chemotherapy) or endocrine therapy within the last 12 months
- Self identifies as Spanish speaking
- Self identifies as Latinx / Latina / Latino
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Non-Spanish speaking
- other diagnosis besides invasive breast cancer (ie Ductal carcinoma in situ (DCIS), fibroadenoma, abnormal mammogram but not yet with final diagnosis, non-breast cancer patients)
- comorbid bipolar affective disorder or psychotic disorder (as self-identified by patient after asking "do you have any other psychiatric conditions")
- inability to physically or psychologically attend group sessions, and by discretion of the study coordinator.
- Patients currently participation in stress reduction or mindfulness groups/interventions will be excluded from participation
- Cancer "survivors" if not in active or endocrine treatment
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 16 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04834154
Start Date
March 15 2021
End Date
June 16 2022
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305